BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 21741498)

  • 1. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
    Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
    Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
    Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
    Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
    Melegari A; Bonaguri C
    Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
    [No Abstract]   [Full Text] [Related]  

  • 10. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
    Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
    Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
    Broadfoot A; Sivertsen T; Baumgart K
    Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the methods used for the detection of antinuclear antibodies].
    Berkem R; Gümüş T; Karakoç E; Acar N
    Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
    Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
    J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
    Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
    Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases.
    González DA; León AC; Varela AR; García MG; Rahola Mde S; Pérez Mdel C; Hernández AG; Falcón MJ; Díaz BB
    Immunol Lett; 2011 Oct; 140(1-2):30-5. PubMed ID: 21684306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing.
    Van Blerk M; Bossuyt X; Humbel R; Mewis A; Servais G; Tomasi JP; Van Campenhout C; Van Hoovels L; Vercammen M; Damoiseaux J; Coucke W; Van de Walle P
    Acta Clin Belg; 2014 Apr; 69(2):83-6. PubMed ID: 24724745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies].
    Ishihara Y
    Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.